Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06873113 · ClinicalTrials.gov registry record · NA
BFRT for Subacromial Pain
A NA study of Shoulder Pain, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06873113: Recruiting NA study of Shoulder Pain, sponsored by University of Florida.
NCT06873113 is a NA study of Shoulder Pain that is actively recruiting participants, run by University of Florida. The registered enrollment target is 36 participants, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06873113, a NA study of Shoulder Pain, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot clinical trial is to learn if blood flow restriction training is safe and feasible in patients with subacromial pain. The main questions the investigators aim to answer are: * What problems do participants with shoulder pain encounter when training with blood flow restriction? * Is it feasible to apply blood flow restriction training as part of a physical therapy intervention? * What are some preliminary effects of blood flow restriction training on the recovery of shoulder function and strength? The investigators will compare active blood flow restriction training to sham (an inactive procedure designed to mimic the active training as closely as possible). Participants will: * Visit the clinic for physical therapy visits and exercise with blood flow restriction training for up to 8 weeks * Visit the clinic for tests before starting the treatment, during the treatment (4 weeks), and after the end of the treatment (8 and 26 weeks).
Primary Outcome
Record the number of individuals a) approached, b) screened, c) qualified, and d) willing to participate. The reasons for participants who do not qualify or refuse to participate will be recorded.
Conditions Studied
Interventions
- DEVICE Active BFRT
- DEVICE Sham BFRT
- BEHAVIORAL Strengthening Exercises with BFRT
- BEHAVIORAL Skilled Physical Therapy Care
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-05-13 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT06873113 shows while recruiting
NCT06873113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Shoulder Pain appearing as the primary indexed condition, and to 4 interventions - of which Active BFRT is the first listed.
NCT06873113 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06873113 about?
NCT06873113 is a clinical study titled "BFRT for Subacromial Pain". The goal of this pilot clinical trial is to learn if blood flow restriction training is safe and feasible in patients with subacromial pain. The main questions the investigators aim to answer are: * What problems do participants with shoulder pain encounter when training with blood flow restriction...
What is the current status of trial NCT06873113?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-05-13. Estimated completion is 2028-12-31.
What conditions does trial NCT06873113 study?
This clinical trial studies the following conditions: Shoulder Pain.
What interventions are being tested in trial NCT06873113?
The interventions under investigation include: Active BFRT (DEVICE), Sham BFRT (DEVICE), Strengthening Exercises with BFRT (BEHAVIORAL), Skilled Physical Therapy Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT06873113?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06873113 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06873113's enrollment target sits among peer trials
36 21st of 27 higher than 7 of 27 other Shoulder Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Outcomes Collection: How Can we do Better?
RECRUITING · NA
-
Zimmer Biomet Shoulder Arthroplasty PMCF
RECRUITING · NA
-
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
RECRUITING · NA
-
Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity in Individuals with Shoulder Pain
ACTIVE NOT RECRUITING · NA
-
How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation
ACTIVE NOT RECRUITING · NA
-
A Randomized Controlled Trial of Best Approach to Care Compared to Diversified Chiropractic Adjustive Technique
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI